Navigation Links
PharmAthene Appoints Jeffrey W. Runge, M.D. to the Company's Board of Directors
Date:12/21/2009

he PharmAthene Board," commented David P. Wright, President and Chief Executive Officer. "With his extensive Federal executive experience in Homeland Security and biodefense, and intimate knowledge and understanding of the challenges and issues facing the biodefense industry, Dr. Runge will be a valuable addition to our Board and we look forward to his contributions as we advance our mission of developing next generation medical countermeasures to protect the American public."

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim(®) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia(®) - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit www.PharmAthene.com.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts,
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
2. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
3. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
4. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
5. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
6. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
7. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
8. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
9. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
10. PharmAthene Reports First Quarter 2009 Financial and Operational Results
11. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014. Applied DNA Sciences, ... provides DNA-based authentication and security solutions and services, has ... Life Sciences, a newly created position, with a starting ... lead APDN’s drive to build its business in pharmaceuticals ... customers, provide guidance to APDN’s R&D efforts, and apply ...
(Date:7/30/2014)... July 30, 2014  Dyadic International, Inc. ("Dyadic") ... patented and proprietary technologies are used to discover, ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... "Tom" Dubinski as Vice President and Chief Financial ... financial and information technology operations for Dyadic and ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 NCERC ... Athmanathan will present his findings on corn stover ... conference this week in Washington, D.C. , ... Energy conference is a testament to the success ... Caupert said. “Thanks to the foresight and vision ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 LayerBio, Inc., ... completion of its first round of seed financing from ... enable preliminary efforts to develop a novel sustained-release product ... of our investors and their commitment to this important ... LayerBio. "Ophthalmology is one of many areas in which ...
Breaking Biology Technology:Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... Ill. and ST. PAUL, Minn., April ... promote and distribute Abbott,s FreeStyle,Navigator Continuous ... Medical MD is the manufacturer,of the ... and the Deltec Cozmo,insulin pump., ...
... Lorus Therapeutics Inc.,(,Lorus,), a biopharmaceutical company specializing ... and technologies for the management,of cancer, today ... aimed at,expanding the therapeutic application of its ... superficial bladder cancer., The new development ...
... to Tap Alternative Energy Business in China, ... Ltd ("JIC" or "the Company") to be renamed ... a wholly-owned subsidiary of HKC,(Holdings) Limited ("HKC (HOLDINGS) ... in three alternative energy projects at the Lunaobao,Wind ...
Cached Biology Technology:Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System 2Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System 3Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System 4Lorus initiates development program exploring novel route of administration for LOR-2040 2Lorus initiates development program exploring novel route of administration for LOR-2040 3Lorus initiates development program exploring novel route of administration for LOR-2040 4JIC Invests in Three New Alternative Energy Projects 2JIC Invests in Three New Alternative Energy Projects 3JIC Invests in Three New Alternative Energy Projects 4JIC Invests in Three New Alternative Energy Projects 5
(Date:7/30/2014)... colors, nature had already perfected the process think ... example. Now scientists are tapping into those secrets to ... plastics. Their paper on using structure or the ... to produce color appears in the ACS journal ... and colleagues point out that currently, plastic manufacturers add ...
(Date:7/30/2014)... today published new research from Bjorn Brembs, professor of ... Germany, with a proof-of-concept figure allowing readers and reviewers ... This represents an important leap forward for scientific ... the quality of a scholarly output. , Figure 3 ... data and their code to F1000Research , and ...
(Date:7/30/2014)... Wallerian degeneration is a subject of major interest ... differentially regulated during the distinct stages of Wallerian ... differentiation and dedifferentiation. Although gene expression responses in ... peripheral nerve injury are known, differences in gene ... unclear. Dr. Dengbing Yao and co-workers from Nantong ...
Breaking Biology News(10 mins):F1000Research brings static research figures to life 2
... techniques, advanced computer simulation and next generation sequencing technology, ... and the Massachusetts Institute of Technology (MIT) have resolved ... chromosomes were first observed under the light microscope by ... that appears in the online edition of Science ...
... known to repair their tissues effortlessly, but can this capacity ... the Stem Cell Program at Boston Children,s Hospital suggests that ... is active in embryonic stem cells, researchers were able to ... tissues in a mouse model. The study also ...
... Bethesda, Md. (Nov. 7, 2013)Obesity has more than doubled ... States in the past 30 years, according to the ... of childhood obesity is a major health concern since ... developing several diseases once considered reserved for adults. These ...
Cached Biology News:UMMS researchers answer century old question about 3D structure of mitotic chromosomes 2UMMS researchers answer century old question about 3D structure of mitotic chromosomes 3UMMS researchers answer century old question about 3D structure of mitotic chromosomes 4Researchers regrow hair, cartilage, bone, soft tissues 2For obese teen girls, aerobic exercise may trump resistance training in health benefits 2For obese teen girls, aerobic exercise may trump resistance training in health benefits 3
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... The standard of the Axima range, ... high mass accuracy, resolution, sensitivity and ... with both linear and reflectron time-of-flight ... reflectron enables the generation of seamless ...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
... miVac Duo is suitable for use with ... organic solvents through to water and some ... centrifugal concentrator capable of removing water and ... formats including tubes, microplates, vials and round ...
Biology Products: